Table of Content

Chapter 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
Chapter 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
Chapter 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. High bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of chronic and infectious diseases
3.4.1.2. Increase in awareness about early disease diagnosis and personalized medicine
3.4.1.3. Increase in number of medical laboratories
3.4.2. Restraints
3.4.2.1. High cost of esoteric testing
3.4.3. Opportunities
3.4.3.1. Technological advancements in esoteric testing
Chapter 4: ESOTERIC TESTING MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Infectious Disease Testing
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Oncology Testing
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Endocrinology Testing
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Genetic Testing
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Toxicology Testing
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
4.7. Immunology Testing
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market share analysis by country
4.8. Neurology Testing
4.8.1. Key market trends, growth factors and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market share analysis by country
4.9. Other Testings
4.9.1. Key market trends, growth factors and opportunities
4.9.2. Market size and forecast, by region
4.9.3. Market share analysis by country
Chapter 5: ESOTERIC TESTING MARKET, BY TECHNOLOGY
5.1. Overview
5.1.1. Market size and forecast
5.2. Enzyme-linked Immunosorbent Assay
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Chemiluminescence Immunoassay
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Mass Spectrometry
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Real Time Polymerase Chain Reaction
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. DNA Sequencing
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
5.7. Flow Cytometry
5.7.1. Key market trends, growth factors and opportunities
5.7.2. Market size and forecast, by region
5.7.3. Market share analysis by country
5.8. Other Technologies
5.8.1. Key market trends, growth factors and opportunities
5.8.2. Market size and forecast, by region
5.8.3. Market share analysis by country
Chapter 6: ESOTERIC TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital-based Laboratories
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Independent and Reference Laboratories
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
Chapter 7: ESOTERIC TESTING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Technology
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Type
7.2.5.1.2. Market size and forecast, by Technology
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Type
7.2.5.2.2. Market size and forecast, by Technology
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Type
7.2.5.3.2. Market size and forecast, by Technology
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Technology
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Type
7.3.5.1.2. Market size and forecast, by Technology
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Type
7.3.5.2.2. Market size and forecast, by Technology
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Type
7.3.5.3.2. Market size and forecast, by Technology
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Type
7.3.5.4.2. Market size and forecast, by Technology
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Type
7.3.5.5.2. Market size and forecast, by Technology
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Type
7.3.5.6.2. Market size and forecast, by Technology
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Technology
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Type
7.4.5.1.2. Market size and forecast, by Technology
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Type
7.4.5.2.2. Market size and forecast, by Technology
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Type
7.4.5.3.2. Market size and forecast, by Technology
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Type
7.4.5.4.2. Market size and forecast, by Technology
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. Rest of Asia-Pacific
7.4.5.5.1. Market size and forecast, by Type
7.4.5.5.2. Market size and forecast, by Technology
7.4.5.5.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Technology
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Type
7.5.5.1.2. Market size and forecast, by Technology
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Type
7.5.5.2.2. Market size and forecast, by Technology
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Type
7.5.5.3.2. Market size and forecast, by Technology
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Type
7.5.5.4.2. Market size and forecast, by Technology
7.5.5.4.3. Market size and forecast, by End User
Chapter 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
Chapter 9: COMPANY PROFILES
9.1. Laboratory Corporation of America Holdings
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. ARUP Laboratories
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.3. Mayo Foundation for Medical Education and Research
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.4. Healius Limited
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.5. Opko Health, Inc.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Quest Diagnostics Inc.
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Sonic Healthcare Limited
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. F. Hoffmann-La Roche Ltd.
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.9. Stanford Health Care
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Athena Esoterix, LLC.
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio



List of Figures

LIST OF FIGURES
FIGURE 01. ESOTERIC TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF ESOTERIC TESTING MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN ESOTERIC TESTING MARKET
FIGURE 04. TOP INVESTMENT POCKETS IN ESOTERIC TESTING MARKET (2023-2032)
FIGURE 05. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTES
FIGURE 08. MODERATE INTENSITY OF RIVALRY
FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL ESOTERIC TESTING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. ESOTERIC TESTING MARKET, BY TYPE, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR ONCOLOGY TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR ENDOCRINOLOGY TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR GENETIC TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR TOXICOLOGY TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR IMMUNOLOGY TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR NEUROLOGY TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR OTHER TESTINGS, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR MASS SPECTROMETRY, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR REAL TIME POLYMERASE CHAIN REACTION, BY COUNTRY 2022 AND 2032(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR DNA SEQUENCING, BY COUNTRY 2022 AND 2032(%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR FLOW CYTOMETRY, BY COUNTRY 2022 AND 2032(%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 28. ESOTERIC TESTING MARKET, BY END USER, 2022 AND 2032(%)
FIGURE 29. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR HOSPITAL-BASED LABORATORIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 30. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR INDEPENDENT AND REFERENCE LABORATORIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 31. ESOTERIC TESTING MARKET BY REGION, 2022 AND 2032(%)
FIGURE 32. U.S. ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 33. CANADA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 34. MEXICO ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 35. GERMANY ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 36. FRANCE ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 37. UK ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 38. ITALY ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 39. SPAIN ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 40. REST OF EUROPE ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 41. JAPAN ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 42. CHINA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 43. INDIA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 44. AUSTRALIA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 45. REST OF ASIA-PACIFIC ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 46. BRAZIL ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 47. SAUDI ARABIA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 48. SOUTH AFRICA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 49. REST OF LAMEA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 50. TOP WINNING STRATEGIES, BY YEAR (2021-2023)
FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT (2021-2023)
FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY (2021-2023)
FIGURE 53. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 54. COMPETITIVE DASHBOARD
FIGURE 55. COMPETITIVE HEATMAP: ESOTERIC TESTING MARKET
FIGURE 56. TOP PLAYER POSITIONING, 2022
FIGURE 57. LABORATORY CORPORATION OF AMERICA HOLDINGS: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 58. LABORATORY CORPORATION OF AMERICA HOLDINGS: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 59. HEALIUS LIMITED: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 60. HEALIUS LIMITED: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 61. OPKO HEALTH, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 62. OPKO HEALTH, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 63. QUEST DIAGNOSTICS INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 64. QUEST DIAGNOSTICS INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 65. SONIC HEALTHCARE LIMITED: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 66. SONIC HEALTHCARE LIMITED: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 67. SONIC HEALTHCARE LIMITED: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 68. F. HOFFMANN-LA ROCHE LTD.: SALES REVENUE, 2020-2022 ($MILLION)
FIGURE 69. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 70. STANFORD HEALTH CARE: NET REVENUE, 2020-2022 ($MILLION)

List of Tables

LIST OF TABLES
TABLE 01. GLOBAL ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 02. ESOTERIC TESTING MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 03. ESOTERIC TESTING MARKET FOR ONCOLOGY TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 04. ESOTERIC TESTING MARKET FOR ENDOCRINOLOGY TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 05. ESOTERIC TESTING MARKET FOR GENETIC TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 06. ESOTERIC TESTING MARKET FOR TOXICOLOGY TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 07. ESOTERIC TESTING MARKET FOR IMMUNOLOGY TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 08. ESOTERIC TESTING MARKET FOR NEUROLOGY TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 09. ESOTERIC TESTING MARKET FOR OTHER TESTINGS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. GLOBAL ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 11. ESOTERIC TESTING MARKET FOR ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2022-2032 ($MILLION)
TABLE 12. ESOTERIC TESTING MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2022-2032 ($MILLION)
TABLE 13. ESOTERIC TESTING MARKET FOR MASS SPECTROMETRY, BY REGION, 2022-2032 ($MILLION)
TABLE 14. ESOTERIC TESTING MARKET FOR REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2022-2032 ($MILLION)
TABLE 15. ESOTERIC TESTING MARKET FOR DNA SEQUENCING, BY REGION, 2022-2032 ($MILLION)
TABLE 16. ESOTERIC TESTING MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2032 ($MILLION)
TABLE 17. ESOTERIC TESTING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022-2032 ($MILLION)
TABLE 18. GLOBAL ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 19. ESOTERIC TESTING MARKET FOR HOSPITAL-BASED LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 20. ESOTERIC TESTING MARKET FOR INDEPENDENT AND REFERENCE LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 21. ESOTERIC TESTING MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 22. NORTH AMERICA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 23. NORTH AMERICA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 24. NORTH AMERICA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 25. NORTH AMERICA ESOTERIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 26. U.S. ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 27. U.S. ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 28. U.S. ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. CANADA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 30. CANADA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 31. CANADA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 32. MEXICO ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 33. MEXICO ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 34. MEXICO ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 35. EUROPE ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 36. EUROPE ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 37. EUROPE ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 38. EUROPE ESOTERIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 39. GERMANY ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 40. GERMANY ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 41. GERMANY ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. FRANCE ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 43. FRANCE ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 44. FRANCE ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. UK ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 46. UK ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 47. UK ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. ITALY ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 49. ITALY ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 50. ITALY ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. SPAIN ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 52. SPAIN ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 53. SPAIN ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 54. REST OF EUROPE ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 55. REST OF EUROPE ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 56. REST OF EUROPE ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 57. ASIA-PACIFIC ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 58. ASIA-PACIFIC ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 59. ASIA-PACIFIC ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 60. ASIA-PACIFIC ESOTERIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 61. JAPAN ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 62. JAPAN ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 63. JAPAN ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. CHINA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 65. CHINA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 66. CHINA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. INDIA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 68. INDIA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 69. INDIA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 70. AUSTRALIA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 71. AUSTRALIA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 72. AUSTRALIA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 74. REST OF ASIA-PACIFIC ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 75. REST OF ASIA-PACIFIC ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 76. LAMEA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 77. LAMEA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 78. LAMEA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 79. LAMEA ESOTERIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 80. BRAZIL ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 81. BRAZIL ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 82. BRAZIL ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. SAUDI ARABIA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 84. SAUDI ARABIA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 85. SAUDI ARABIA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. SOUTH AFRICA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 87. SOUTH AFRICA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 88. SOUTH AFRICA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 89. REST OF LAMEA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 90. REST OF LAMEA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 91. REST OF LAMEA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 92. LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY EXECUTIVES
TABLE 93. LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT
TABLE 94. LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCT SEGMENTS
TABLE 95. LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCT PORTFOLIO
TABLE 96. LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY STRATERGIES
TABLE 97. ARUP LABORATORIES: KEY EXECUTIVES
TABLE 98. ARUP LABORATORIES: COMPANY SNAPSHOT
TABLE 99. ARUP LABORATORIES: SERVICE SEGMENTS
TABLE 100. ARUP LABORATORIES: PRODUCT PORTFOLIO
TABLE 101. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH: KEY EXECUTIVES
TABLE 102. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH: COMPANY SNAPSHOT
TABLE 103. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH: SERVICE SEGMENTS
TABLE 104. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH: PRODUCT PORTFOLIO
TABLE 105. HEALIUS LIMITED: KEY EXECUTIVES
TABLE 106. HEALIUS LIMITED: COMPANY SNAPSHOT
TABLE 107. HEALIUS LIMITED: SERVICE SEGMENTS
TABLE 108. HEALIUS LIMITED: PRODUCT PORTFOLIO
TABLE 109. OPKO HEALTH, INC.: KEY EXECUTIVES
TABLE 110. OPKO HEALTH, INC.: COMPANY SNAPSHOT
TABLE 111. OPKO HEALTH, INC.: PRODUCT SEGMENTS
TABLE 112. OPKO HEALTH, INC.: PRODUCT PORTFOLIO
TABLE 113. OPKO HEALTH, INC.: KEY STRATERGIES
TABLE 114. QUEST DIAGNOSTICS INC.: KEY EXECUTIVES
TABLE 115. QUEST DIAGNOSTICS INC.: COMPANY SNAPSHOT
TABLE 116. QUEST DIAGNOSTICS INC.: SERVICE SEGMENTS
TABLE 117. QUEST DIAGNOSTICS INC.: PRODUCT PORTFOLIO
TABLE 118. QUEST DIAGNOSTICS INC.: KEY STRATERGIES
TABLE 119. SONIC HEALTHCARE LIMITED: KEY EXECUTIVES
TABLE 120. SONIC HEALTHCARE LIMITED: COMPANY SNAPSHOT
TABLE 121. SONIC HEALTHCARE LIMITED: SERVICE SEGMENTS
TABLE 122. SONIC HEALTHCARE LIMITED: PRODUCT PORTFOLIO
TABLE 123. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
TABLE 124. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 125. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
TABLE 126. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 127. STANFORD HEALTH CARE: KEY EXECUTIVES
TABLE 128. STANFORD HEALTH CARE: COMPANY SNAPSHOT
TABLE 129. STANFORD HEALTH CARE: SERVICE SEGMENTS
TABLE 130. STANFORD HEALTH CARE: PRODUCT PORTFOLIO
TABLE 131. ATHENA ESOTERIX, LLC.: KEY EXECUTIVES
TABLE 132. ATHENA ESOTERIX, LLC.: COMPANY SNAPSHOT
TABLE 133. ATHENA ESOTERIX, LLC.: SERVICE SEGMENTS
TABLE 134. ATHENA ESOTERIX, LLC.: PRODUCT PORTFOLIO